Robert Edward  Kelly net worth and biography

Robert Kelly Biography and Net Worth

EVP of Zoetis
Mr. Robert Kelly is the EVP of Zoetis.

What is Robert Edward Kelly's net worth?

The estimated net worth of Robert Edward Kelly is at least $1.69 million as of February 11th, 2021. Mr. Kelly owns 10,029 shares of Zoetis stock worth more than $1,689,987 as of March 28th. This net worth estimate does not reflect any other assets that Mr. Kelly may own. Learn More about Robert Edward Kelly's net worth.

How do I contact Robert Edward Kelly?

The corporate mailing address for Mr. Kelly and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected]. Learn More on Robert Edward Kelly's contact information.

Has Robert Edward Kelly been buying or selling shares of Zoetis?

Robert Edward Kelly has not been actively trading shares of Zoetis over the course of the past ninety days. Most recently, Robert Edward Kelly sold 2,055 shares of the business's stock in a transaction on Thursday, April 1st. The shares were sold at an average price of $158.05, for a transaction totalling $324,792.75. Learn More on Robert Edward Kelly's trading history.

Who are Zoetis' active insiders?

Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.

Are insiders buying or selling shares of Zoetis?

In the last twelve months, insiders at the sold shares 13 times. They sold a total of 49,823 shares worth more than $8,985,800.22. The most recent insider tranaction occured on March, 18th when EVP Roxanne Lagano sold 923 shares worth more than $159,983.59. Insiders at Zoetis own 0.1% of the company. Learn More about insider trades at Zoetis.

Information on this page was last updated on 3/18/2024.

Robert Edward Kelly Insider Trading History at Zoetis

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2021Sell2,055$158.05$324,792.75
2/11/2021Sell2,054$161.15$331,002.1010,029View SEC Filing Icon  
See Full Table

Robert Edward Kelly Buying and Selling Activity at Zoetis

This chart shows Robert Edward Kelly's buying and selling at Zoetis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zoetis Company Overview

Zoetis logo
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
Read More

Today's Range

Now: $167.64
Low: $167.63
High: $168.98

50 Day Range

MA: $186.36
Low: $165.71
High: $199.94

2 Week Range

Now: $167.64
Low: $151.03
High: $201.92

Volume

71,434 shs

Average Volume

2,684,909 shs

Market Capitalization

$76.76 billion

P/E Ratio

33.07

Dividend Yield

1.04%

Beta

0.87